Defective expression and function of the leukocyte associated ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Colombo, Barbara M ^a   Canevali, Paolo ^b,c   Magnani, Ottavia ^a   Rossi, Edoardo ^b   Puppo, Francesco ^a   Zocchi, Maria Raffaella ^c   Poggi, Alessandro ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; B LYMPHOCYTE RECEPTOR; CD20 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEFLAZACORT; FLUOCORTOLONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOCYTE ASSOCIATED IMMUNOGLOBULIN LIKE RECEPTOR 1; LYMPHOCYTE RECEPTOR; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; CALCIUM; COLLAGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; STROMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSCRIPTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN TRANSPORT;

PHYTOLACCACEAE;

ADULT; AGED; B-LYMPHOCYTES; CALCIUM; CASE-CONTROL STUDIES; CELLS, CULTURED; COLLAGEN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NF-KAPPA B; PROTEIN TRANSPORT; RECEPTORS, IMMUNOLOGIC; SCLERODERMA, SYSTEMIC; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84857081501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031903     Document Type: Article

References (34)

1. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, et al. (1997) LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7: 283-290.
2. Meyaard L, (2008) The inhibitory collagen receptor LAIR-1 (CD305). J Leukoc Biol 83: 799-803.
3. Meyaard L, Hurenkamp J, Clevers H, Lanier LL, Phillips JH, (1999) Leukocyte associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. J Immunol 16: 5800-5804.
4. Poggi A, Pella N, Morelli L, Spada F, Revello V, et al. (1995) p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur J Immunol 25: 369-376.
5. Poggi A, Tomasello E, Revello V, Nanni L, Costa P, et al. (1997) p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Int Immunol 9: 1271-1279.
6. Poggi A, Tomasello E, Ferrero E, Zocchi MR, Moretta L, (1999) p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor. Eur J Immunol 28: 2086-2091.
7. Jansen CA, Cruijsen CW, de Ruiter T, Nanlohy N, Willems N, et al. (2007) Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 37: 914-924.
8. van der Vuurst de Vries AR, Clevers H, Logtenberg T, Meyaard L, (1999) Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptor mediated signaling. Eur J Immunol 29: 3160-3167.
9. Merlo A, Tenca C, Fais F, Battini L, Ciccone E, et al. (2005) Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. Clin Diagn Lab Immunol 12: 705-712.
10. Lebbink RJ, de Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, et al. (2006) Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 203: 1419-1425.
11. Lebbink RJ, Raynal N, de Ruiter T, Bihan DG, Farndale RW, et al. (2009) Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III. Matrix Biol 28: 202-210.
12. Jiang L, Barclay AN, (2009) New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1). Eur J Immunol 39: 1167-1175.
13. Lebbink RJ, van den Berg MC, de Ruiter T, Raynal N, van Roon JA, et al. (2008) The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction. J Immunol 180: 1662-1669.
14. Tang X, Narayanan S, Peruzzi G, Apara A, Natarajan K, et al. (2009) A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor-1 with collagens. J Immunol 182: 5446-5452.
15. Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, et al. (2008) Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. Leukemia 22: 980-988.
16. Rahman A, Isenberg DA, (2008) Systemic lupus erythematosus. N Engl J Med 358: 929-939.
17. La Cava A, (2010) Targeting B cells with biologics in systemic lupus erythematosus. Expert Opin Biol Ther pp. 1555-1561.
18. Sanz I, Lee FE, (2010) B cells as therapeutic targets in SLE, Nature Rev Rheumatol 6: 326-337.
19. Poggi A, Pardi R, Pella N, Morelli L, Sivori S, et al. (1993) CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. Eur J Immunol 1993; 23: 2454-63.
20. Poggi A, Prevosto C, Catellani S, Rocco I, Garuti A, et al. (2010) Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells. Br J Haematol 151: 252-264.
21. Zocchi MR, Bottino C, Ferrini S, Moretta L, Moretta A, (1987) A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function. J Exp Med 166: 319-326.
22. Musso A, Zocchi MR, Poggi A, (2011) Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival. Haematologica 96: 16-23.
23. Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, et al. (2008) Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 26: 562-569.
24. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, et al. (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372.
25. Youinou P, Renaudineau Y, (2011) CD5 expression in B cells from patients with systemic lupus erythematosus. Crit Rev Immunol 31: 31-42.
26. Hahn BH, (2011) Targeted therapies in systemic lupus erythematosus: successes, failures and future. Ann Rheum Dis 70 (Suppl 1): i64-i66.
27. Sestak AL, Fürnrohr BG, Harley JB, Merrill JT, Namjou B, (2011) The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis 70 (Suppl 1): i37-43.
28. Gayed M, Gordon C, (2010) Novel treatments for systemic lupus erythematosus. Curr Opin Investig Drugs 11: 1256-1264.
29. Doria A, Zen M, Canova M, Bettio S, Bassi N, et al. (2010) SLE diagnosis and treatment: when early is early. Autoimmun Rev 10: 55-60.
30. Liossis S-N C, Kovacs B, Dennis G, Kammer GM, Tsokos GC, (1996) B cells from patients with Systemic Lupus Erythematosus display abnormal antigen receptor-mediated signal transduction events. J Clin Invest 98: 2549-2557.
31. Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, et al. (2011) Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresse humoral immunity in Systemic Lupus Erythematosus. J Immunol 186: 4223-4233.
32. Poggi A, Pellegatta F, Leone BE, Moretta L, Zocchi MR, (2000) Engagement of the leukocyteassociated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias. Eur J Immunol 30: 2751-2758.
33. Zocchi MR, Pellegatta F, Pierri I, Gobbi M, Poggi A, (2001) Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells. Eur J Immunol 31: 3667-3675.
34. Bonaccorsi I, Cantoni C, Carrega P, Oliveri D, Lui G, et al. (2010) The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production. PLoS One 30: e15080.